Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Stem Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00435084
What this trial is testing

A Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLL

Who this might be right for
B-cell Chronic Lymphocytic Leukemia
Valerio Therapeutics 10
Testing effectiveness (Phase 2)WithdrawnNCT03982992
What this trial is testing

Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab

Who this might be right for
B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell TransplantationB-Cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia+2 more
Ludwig-Maximilians - University of Munich
Testing effectiveness (Phase 2)Study completedNCT02572167
What this trial is testing

Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Seagen Inc. 93
Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT06532084
What this trial is testing

Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

Who this might be right for
Acute Myeloid Leukemia, in RelapseMyelodysplastic SyndromesChronic Myeloid Leukemia+1 more
St. Petersburg State Pavlov Medical University 88
Not applicableUnknownNCT06134570
What this trial is testing

ALDH1A1 Expression in Invasive Mammary Carcinoma

Who this might be right for
Breast Cancer
Sohag University 60
Large-scale testing (Phase 3)Ended earlyNCT00176839
What this trial is testing

Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Leukemia, Lymphocytic, AcuteAMLMDS
Masonic Cancer Center, University of Minnesota 11
Testing effectiveness (Phase 2)Study completedNCT05115630
What this trial is testing

Off-the-shelf NK Cells + SCT for Myeloid Malignancies

Who this might be right for
Myeloid MalignanciesAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
M.D. Anderson Cancer Center 24
Not applicableStudy completedNCT03654599
What this trial is testing

Effects of Digital Stories Intervention on Psychosocial Well-being

Who this might be right for
Bone Marrow TransplantInformation DisclosureHematopoietic Stem Cell Transplantation+5 more
Arizona State University 202
Not applicableStudy completedNCT02677987
What this trial is testing

The "Light for the Brain" Study

Who this might be right for
Hematopoietic Stem Cell TransplantationCognitive ImpairmentsSleep+3 more
Northwestern University 47
Large-scale testing (Phase 3)Study completedNCT00495287
What this trial is testing

A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous Leukemia
Northern Italy Leukemia Group 573
Large-scale testing (Phase 3)Active Not RecruitingNCT04923893
What this trial is testing

Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 743
Early research (Phase 1)WithdrawnNCT02845414
What this trial is testing

Study of CD133KDEL Toxin in the Treatment for Solid Tumors

Who this might be right for
Solid Tumors
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Ended earlyNCT00143884
What this trial is testing

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

Who this might be right for
LeukemiaLymphoma, Low-GradeLymphoma, Non-Hodgkin's+2 more
University of Michigan Rogel Cancer Center 30
Not applicableStudy completedNCT00445744
What this trial is testing

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+19 more
Fred Hutchinson Cancer Center 52
Not applicableUnknownNCT03759899
What this trial is testing

HAECs Are Preliminarily Applied in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Leukemia
Peking University People's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06483906
What this trial is testing

Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.

Who this might be right for
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 56
Testing effectiveness (Phase 2)Study completedNCT00004172
What this trial is testing

Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University
Large-scale testing (Phase 3)Active Not RecruitingNCT00114101
What this trial is testing

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Who this might be right for
DS Stage I Multiple MyelomaDS Stage II Multiple MyelomaDS Stage III Multiple Myeloma+2 more
National Cancer Institute (NCI) 460
Not applicableStudy completedNCT02425800
What this trial is testing

Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells

Who this might be right for
Benign Prostatic HyperplasiaProstate Carcinoma
Wake Forest University Health Sciences 43
Next Page